Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Duke Blue Light Controls Gene Expression

Published: Wednesday, October 03, 2012
Last Updated: Wednesday, October 03, 2012
Bookmark and Share
New approach could greatly improve ability of researchers and physicians to control gene expression.

Using blue light, Duke University bioengineers have developed a system for ordering genes to produce proteins, an advance they said could prove invaluable in clinical settings as well as in basic science laboratories.

This new approach could greatly improve the ability of researchers and physicians to control gene expression, which is the process by which genes give instructions for the production of proteins key to all living cells.

"We can now, with our method, make gene expression reversible, repeatable, tunable, and specific to different regions of a gene," said Lauren Polstein, a graduate student working in the laboratory of Charles Gersbach, assistant professor of biomedical engineering at Duke's Pratt School of Engineering. "Current methods of getting genes to express can achieve some of those characteristics, but not all at once."

The new system can also control where the genes are expressed in three dimensions, which becomes especially important for researchers attempting to bioengineer living tissues.

"The light-based strategy allows us to regulate gene expression for biotechnology and medical applications, as well as for gaining a better understanding of gene function, interactions between cells, and how tissues develop into particular shapes," Polstein said.

The results of the Duke experiments were published online in the Journal of the American Chemical Society. The research was supported by a Faculty Early Career Development Award from the National Science Foundation and a Director's New Innovator Award from the National Institutes of Health.

The Duke system, which has been dubbed LITEZ (Light Induced Transcription using Engineered Zinc finger proteins), combines proteins from two diverse sources. The light-sensitive proteins are derived from a common flowering plant (Arabidopsis thaliana).

"We hijacked the specific proteins in plants that allows them to sense the length of the day," Gersbach said.

The second protein is in a class of so-called zinc finger proteins, which can be readily engineered to attach to specific regions of a gene. They are ubiquitous in biomedical research.

These new fusions of plant and zinc finger proteins are introduced into a colony of human cells growing in a Petri dish. The dish is placed atop a blue LED light display designed and built by Polstein. When the light is turned on, the part of the protein that turns genes on is recruited to whatever gene the researchers have targeted with the zinc finger protein and this gene "lights up."

"By placing a mask, or stencil over the cells, we can control which cells turn on the gene and which cells do not," Polstein said. "We can control the expression by turning the light on or off, changing the light's intensity, or varying the location of light."

As a whimsical example, the researchers created the iconic blue Duke "D" by covering the cells with a "D" mask.

"All biological systems depend on gene expression," Gersbach said. "The challenge facing bioengineering researchers is trying to synthetically recreate processes that occur in nature."

"LITEZ is a powerful tool that gives us precise control of gene expression with high resolution in both space and time," Gersbach said. "It also has the potential to be incorporated into different applications in medicine or industry, including gene therapy, metabolic engineering, synthetic biology, and biopharmaceutical production."

The researchers are now refining their approach to create complex tissues by controlling cell differentiation, as well as the morphology, or shape, of the tissues that these cells make.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Tinkering Doubles Cancer Drug’s Efficacy
Researchers have packaged a widely used cancer drug into nanoparticles, more than doubling its effectiveness at destroying tumors.
Thursday, August 06, 2015
Researchers Learn To Measure Aging Process In Young Adults
Biological measures may be combined to determine whether people are aging faster or slower than their peers.
Tuesday, July 07, 2015
Outsmarting HIV With Vaccine Antigens Made to Order
AIDS vaccine researchers may be one step closer to outwitting HIV, thanks to designer antibodies and antigens made to order at Duke University.
Thursday, July 02, 2015
Animals’ Genomic Buffers May Help Humans
Researchers at Duke University School of Medicine and Brigham and Women’s Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.
Wednesday, July 01, 2015
New Gene Influences Apple or Pear Shape, Risk of Future Disease
Duke researchers have discovered that a gene called Plexin D1 controls both where fat is stored and how fat cells are shaped.
Tuesday, March 24, 2015
Boy or Girl? Lemur Scents Have the Answer
A new study finds that a pregnant lemur’s signature scent depends in part on whether she’s carrying a girl or a boy.
Friday, February 27, 2015
Duke Awarded $10.4 Million Contract To Continue Developing Radiation Test
The blood test will be able to tell in hours how much radiation a person has absorbed from a nuclear incident.
Friday, February 20, 2015
Bacterial Defense Mechanism Targets Duchenne Muscular Dystrophy
Gene therapy approach could treat 60 percent of Duchenne Muscular Dystrophy patients.
Friday, February 20, 2015
First Contracting Human Muscle Grown in Laboratory
Researchers at Duke University report the first lab-grown, contracting human muscle, which could revolutionize drug discovery and personalized medicine.
Wednesday, January 14, 2015
Drugs to Block Angiogenesis Could Provide New Treatment for TB
Blood supply gives invaders oxygen and a way out.
Monday, November 24, 2014
Gene Required for Recovery from Bacterial Infection Identified
Duke researchers have uncovered the genes that are normally activated during recovery from bacterial infection in the C. elegans worm. The finding could be key to new antibiotics and countering auto-immune disorders.
Monday, October 27, 2014
Nanoparticles Accumulate Quickly in Wetland Sediment
Aquatic food chains might be harmed by molecules "piggybacking" on carbon nanoparticles.
Friday, October 10, 2014
Cancer-Fighting Drugs Might Also Stop Malaria Early
A number of compounds have been identified which could be used to fight malaria.
Wednesday, August 27, 2014
Ubiquitous Protein Controls Copying of Resistant DNA
Researchers have demonstrated how the protein could put antibiotic-resistant bugs in handcuffs.
Monday, June 09, 2014
Cancer’s Thirst For Copper Can Be Targeted
Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer.
Thursday, April 10, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!